WGBSD Financials 07/16/2014 04:41:42
WaferGen Bio-Systems, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 1,305 586 523 2,167
Cost of Revenue 574 421 1,402 862
Gross Profit 731 165 (879) 1,305
Operating Expenses
Research and Development 5,400 6,162 8,291 6,714
Sales, General and Admin. 5,253 3,770 9,533 7,170
Non-Recurring Items - - - -
Other - - - -
Operating Income (9,922) (9,766) (18,703) (12,580)
Income From Continuing Operations
Add'l Income/Expense Items (3,457) 3,650 8,921 523
Earnings Before Interest and Tax (13,379) (6,116) (9,782) (12,056)
Interest Expense 2,881 2,083 3,336 31
Earnings Before Tax (16,260) (8,198) (13,118) (12,087)
Income Tax 6 (21) 27 -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (21,237) (8,177) (13,145) (12,087)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (16,266) (8,177) (13,145) (12,087)
Preferred Stock and Other Adjustments (1,446) (802) (9,693) (716)
Net Income Applicable to Common Shareholders (17,712) (8,978) (22,838) (12,803)